Details for New Drug Application (NDA): 062885
✉ Email this page to a colleague
NDA 062885 describes TRIMOX, which is a drug marketed by Apothecon and is included in eight NDAs. Additional details are available on the TRIMOX profile page.
The generic ingredient in TRIMOX is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
The generic ingredient in TRIMOX is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
Summary for 062885
| Tradename: | TRIMOX |
| Applicant: | Apothecon |
| Ingredient: | amoxicillin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062885
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | 125MG/5ML | ||||
| Approval Date: | Mar 8, 1988 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | 250MG/5ML | ||||
| Approval Date: | Mar 8, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
